Patents by Inventor Stephan Ruetz

Stephan Ruetz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds which affect mRNA stability and uses therefor
    Patent number: 6635671
    Abstract: Compounds which induce degradation of mRNA which contains one or more mRNA instability sequences are provided for use as pharmaceuticals, e.g. for use in the prophylaxis or treatment of diseases and medical conditions in general having an etiology associated with the increased or prolonged stability of mRNAs which contain one or more mRNA instability sequences, and which on prolonged or inappropriate expression typically give rise to undesirable effects, e.g. cancer cell growth or an unwanted inflammatory response.
    Type: Grant
    Filed: August 15, 2001
    Date of Patent: October 21, 2003
    Assignee: Novation Pharmaceuticals Inc.
    Inventors: Tania Kastelic, Dominique Cheneval, Stephan Ruetz